论文部分内容阅读
目的:探讨熊去氧胆酸联合辛伐他汀治疗脂肪肝合并高脂血症的临床疗效。方法:选取我院于2015年5月至2016年5月收治的脂肪肝合并高脂血症患者86例作为临床研究对象,随机将患者分为两组:对照组43例,采用熊去氧胆酸进行治疗;观察组43例,采用熊去氧胆酸联合辛伐他汀进行治疗。比较两组患者的治疗效果。结果:观察组患者的肝功能指标和血脂指标明显优于对照组,治疗总有效率明显高于对照组,结果对比具有明显差异性(P<0.05)。结论:熊去氧胆酸联合辛伐他汀治疗脂肪肝合并高脂血症的临床疗效良好,值得推广使用。
Objective: To investigate the clinical efficacy of ursodeoxycholic acid and simvastatin in the treatment of fatty liver complicated with hyperlipidemia. Methods: Totally 86 patients with fatty liver complicated with hyperlipidemia admitted to our hospital from May 2015 to May 2016 were selected as the clinical study subjects. The patients were randomly divided into two groups: control group (43 cases), ursodeoxycholic acid Acid for treatment; observation group 43 cases, ursodeoxycholic acid combined with simvastatin for treatment. The treatment effect of two groups of patients was compared. Results: The liver function indexes and blood lipid indexes of the observation group were significantly better than those of the control group. The total effective rate of the treatment group was significantly higher than that of the control group (P <0.05). Conclusion: Ursodeoxycholic acid combined with simvastatin has good clinical efficacy in the treatment of fatty liver complicated with hyperlipidemia, which is worthy of promotion.